Loading data
SRRKNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 33.19 m USD | 18.82 m USD |
| Research and development expense | 208.44 m USD | 184.55 m USD | 121.9 m USD | 124.44 m USD | 108.47 m USD |
| Operating profit | -384.65 m USD | -252.05 m USD | -171.3 m USD | -134.37 m USD | -129.92 m USD |
| Net income (reported basis) | -378 m USD | -246 m USD | -166 m USD | -135 m USD | -131.8 m USD |
| Basic earnings per share | -3.29 USD/share | -2.47 USD/share | -1.99 USD/share | -2.26 USD/share | -3.59 USD/share |
| Diluted earnings per share | -3.29 USD/share | -2.47 USD/share | -1.99 USD/share | -2.26 USD/share | -3.59 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.